Kaempferia parviflora rhizome extract and Myristica fragrans volatile oil increase the levels of monoamine neurotransmitters and impact the proteomic profiles in the rat hippocampus: Mechanistic insights into their neuroprotective effects

10.1016/j.jtcme.2017.01.002

Waluga Plaingam；Siriporn Sangsuthum；Wannee Angkhasirisap；Tewin Tencomnao

Kaempferia parviflora ； Myristica fragrans ； Neurotransmitters ； Rat hippocampal proteomics ； Neuroprotection

Journal of Traditional and Complementary Medicine

7卷4期（2017 / 10 / 01）

538 - 552

英文

Potentially useful in the treatment of neurodegenerative disorders, Kaempferia parviflora and Myristica fragrans have been shown to possess a wide spectrum of neuropharmacological activities and neuroprotective effects in vivo and in vitro. In this study, we determined whether and how K. parviflora ethanolic extract and M. fragrans volatile oil could influence the levels of neurotransmitters and the whole proteomic profile in the hippocampus of Sprague Dawley (SD) rats. The effects of K. parviflora and M. fragrans on protein changes were analyzed by two-dimensional gel electrophoresis (2D-gel), and proteins were identified by liquid chromatography tandem mass spectrometry (LC-MS/MS). The target proteins were then confirmed by Western blot. The levels of neurotransmitters were evaluated by reversed-phase high-performance liquid chromatography (RP-HPLC). The results showed that K. parviflora, M. fragrans and fluoxetine (the control drug for this study) increased serotonin, norepinephrine and dopamine in the rat hippocampus compared to that of the vehicle-treated group. Our proteomic data showed that 37 proteins in the K. parviflora group were up-regulated, while 14 were down-regulated, and 27 proteins in the M. fragrans group were up-regulated, while 16 were down-regulated. In the fluoxetine treatment group, we found 29 proteins up-regulated, whereas 14 proteins were down-regulated. In line with the proteomic data, the levels of GFAP, PDIA3, DPYSL2 and p-DPYSL2 were modified in the SD rat groups treated with K. parviflora, M. fragrans and fluoxetine as confirmed by Western blot. K. parviflora and M. fragrans mediated not only the levels of monoamine neurotransmitters but also the proteomic profiles in the rat hippocampus, thus shedding light on the mechanisms targeting neurodegenerative diseases.

1. Chen, C-L,Tsai, W-H,Chen, C-J,Pan, T-M(2016).Centella asiatica extract protects against amyloid β1-40-induced neurotoxicity in neuronal cells by acti-vating the antioxidative defence system.J Tradit Complement Med.,6,362-369.
   連結：
2. Hamidpour, M,Hamidpour, R,Hamidpour, S,Shahlari, M(2014).Chemistry, pharmacology, and medicinal property of Sage (Salvia) to prevent and cure illnesses such as obesity, diabetes, depression, dementia, lupus, autism, heart disease, and cancer.J Tradit Complement Med.,4,82-88.
   連結：
3. Lin, S-H,Chang, H-C,Chen, P-J,Hsieh, C-L,Su, K-P,Sheen, L-Y(2013).The antidepressant-like effect of ethanol extract of daylily flowers（金針花 Jīn Zhēn Huā）in rats.J Tradit Complement Med,3,53-61.
   連結：
4. Subash, S,Essa, MM,Al-Asmi, A(2014).Pomegranate from Oman alleviates the brain oxidative damage in transgenic mouse model of Alzheimer's disease.J Tradit Complement Med,4,232-238.
   連結：
5. (2012).Synaptic Plasticity.Springer.
6. Akbar, M,Essa, MM,Daradkeh, G(2016).Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.Brain Res,1637,34-55.
7. Arimura, N,Kaibuchi, K(2007).Neuronal polarity: from extracellular signals to intra-cellular mechanisms.Nat Rev Neurosci,8,194-205.
8. Azuma, T,Tanaka, Y,Kikuzaki, H.(2008).Phenolic glycosides from Kaempferia parviflora.Phytochemistry,69,2743-2748.
9. Bhuiyan, MMH,Mohibbullah, M,Hannan, MA(2015).The neuritogenic and synaptogenic effects of the ethanolic extract of radix Puerariae in cultured rat hippocampal neurons.J Ethnopharmacol,173,172-182.
10. Brooks, BW,Foran, CM,Richards, SM(2003).Aquatic ecotoxicology of fluoxetine.Toxicol Lett,142,169-183.
11. Ciavardelli, D,Silvestri, E,Del Viscovo, A(2010).Alterations of brain and cerebellar proteomes linked to Ab and tau pathology in a female triple-transgenic murine model of Alzheimer's disease.Cell Death Dis,1,e90.
12. Cobb, J,O'Neill, K,Milner, J(2016).Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.Neuroscience,316,209-220.
13. Duff, K,Paulsen, JS,Beglinger, LJ,Langbehn, DR,Stout, JC,Group P-HIotHS(2007).Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.Biol Psychiatry,62,1341-1346.
14. Duncan, J,Johnson, S,Ou, X-M(2012).Monoamine oxidases in major depressive disorder and alcoholism.Drug Discov Ther,6,112-122.
15. Erickson, RR,Dunning, LM,Olson, DA(2005).In cerebrospinalfluid ER chaperones ERp57 and calreticulin bind β-amyloid.Biochem Biophys Res Commun,332,50-57.
16. Forrester, MB(2005).Nutmeg intoxication in Texas, 1998-2004.Hum Exp Toxicol.,24,563-566.
17. Freitas-Andrade, M,Naus, C(2016).Astrocytes in neuroprotection and neuro-degeneration: the role of connexin43 and pannexin1.Neuroscience,323,207-221.
18. Garcia-Huerta, P,Troncoso-Escudero, P,Jerez, C,Hetz, C,Vidal, RL(2016).The intersection between growth factors, autophagy and ER stress: a new target to treat neurodegenerative diseases?.Brain Res.,1649(Pt B),173-180.
19. Garcia-Miralles, M,Ooi, J,Bardile, CF(2016).Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease.Exp Neurol,278,4-10.
20. Gordon, GR,Baimoukhametova, DV,Hewitt, SA,Rajapaksha, WKJ,Fisher, TE,Bains, JS(2005).Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy.Nat Neurosci,8,1078-1086.
21. Halliday, M,Mallucci, GR(2014).Targeting the unfolded protein response in neuro-degeneration: a new approach to therapy.Neuropharmacology,76,169-174.
22. Hawiset, T,Muchimapura, S,Wattanathorn, J,Sripanidkulchai, B(2011).Screening neuropharmacological activities of Kaempferia parviflora (Krachai Dam) in healthy adult male rats.Am J Appl Sci,8,695.
23. He, J,Shi, W,Guo, Y,Chai, Z(2014).ERp57 modulates mitochondrial calcium uptake through the MCU.FEBS Lett,588,2087-2094.
24. Hol, EM,Pekny, M(2015).Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system.Curr Opin Cell Biol.,32,121-130.
25. Iyer, RI,Jayaraman, G,Ramesh, A(2009).In vitro responses and production of phyto-chemicals of potential medicinal value in nutmeg, Myristica fragrans Houtt.Indian J Sci Technol,2,65-70.
26. Johnson, S,Stockmeier, CA,Meyer, JH(2011).The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder.Neuropsychopharmacology,36,2139-2148.
27. Jung, M,Park, M(2007).Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa.Molecules,12,2130-2139.
28. Kamińska, K,Gołembiowska, K,Rogóż, Z(2013).Effect of risperidone on the fluoxetine-induced changes in extracellular dopamine, serotonin and noradrenaline in the rat frontal cortex.Pharmacol Rep.,65,1144-1151.
29. Koide, T,Aleksic, B,Ito, Y(2010).A two-stage case-control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects.J Hum Genet,55,469-472.
30. Kumar, R,Palit, G,Dhawan, BN(2003).Comparative behavioural effects of typical and atypical antipsychotic drugs in rhesus monkey.Eur J Pharmacol,462,133-138.
31. Latha, P,Sindhu, P,Suja, S,Geetha, B,Pushpangadan, P,Rajasekharan, S(2012).Pharmacology and chemistry of Myristica fragrans Houtt.-a review.J Spices Aromat Crop.,14
32. Liu, Y,Liu, P,Dai, R(2012).Analysis of plasma proteome from cases of the different traditional Chinese medicine syndromes in patients with chronic hepatitis B.J Pharm Biomed Anal,59,173-178.
33. Mak, TN,Caldeira, S,(2014).The Role of Nutrition in Active and Healthy Ageing.
34. Malagié, I,David, DJ,Jolliet, P,Hen, R,Bourin, M,Gardier, AM(2002).Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT1B receptor knock-out mice.Eur J Pharmacol,443,99-104.
35. Middeldorp, J,Hol, E(2011).GFAP in health and disease.Prog Neurobiol,93,421-443.
36. Moinuddin, G,Devi, K,Khajuria, DK(2012).Evaluation of the anti-depressant activity of Myristica fragrans (Nutmeg) in male rats.Avicenna J Phytomed,2,72.
37. Narayan, PJ,Lill, C,Faull, R,Curtis, MA,Dragunow, M(2015).Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain.Neurobiol Dis,74,281-294.
38. Ng, J,Papandreou, A,Heales, SJ,Kurian, MA(2015).Monoamine neurotransmitter disorders [mdash] clinical advances and future perspectives.Nat Rev Neurol.,11,567-584.
39. Niisato, E,Nagai, J,Yamashita, N,Nakamura, F,Goshima, Y,Ohshima, T(2013).Phosphorylation of CRMP2 is involved in proper bifurcation of the apical dendrite of hippocampal CA1 pyramidal neurons.Dev Neurobiol,73,142-151.
40. Olajide, OA,Ajayi, FF,Ekhelar, AI,Awe, SO,Makinde, JM,Alada, A(1999).Biological effects of Myristica fragrans (nutmeg) extract.Phytother Res,13,344-345.
41. Pal, M,Srivastava, M,Soni, D,Kumar, A,Tewari, S(2011).Composition and anti-microbial activity of essential oil of Myristica fragrans from Andaman Nicobar Island.Int J Pharm Life Sci,2,1115-1117.
42. Patanasethanont, D,Nagai, J,Yumoto, R(2007).Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function.J Pharm Sci.,96,223-233.
43. Pekny, M,Wilhelmsson, U,Bogestål, YR,Pekna, M.The role of astrocytes and complement system in neural plasticity.International Review of Neurobiology,82
44. Prabuseenivasan, S,Jayakumar, M,Ignacimuthu, S(2006).In vitro antibacterial activity of some plant essential oils.BMC Complement Altern Med.,6,1.
45. Quach, T,Honnorat, J,Kolattukudy, P,Khanna, R,Duchemin, A(2015).CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases.Mol Psychiatry.,20,1037-1045.
46. Robert, A,Monsinjon, T,Delbecque, J-P(2016).Neuroendocrine disruption in the shore crab Carcinus maenas: effects of serotonin and fluoxetine on chh- and mih-gene expression, glycaemia and ecdysteroid levels.Aquat Toxicol.,175,192-204.
47. Sa-nguanmoo, P,Poovorawan, Y(2007).Myristica fragrans Houtt. methanolic extract induces apoptosis in a human leukemia cell line through SIRT1 mRNA down-regulation.J Med Assoc Thai.,90,2422-2428.
48. Sawasdee, P,Sabphon, C,Sitthiwongwanit, D,Kokpol, U(2009).Anticholinesterase activity of 7-methoxyflavones isolated from Kaempferia parviflora.Phytother Res,23,1792-1794.
49. Spencer, JP(2009).Flavonoids and brain health: multiple effects underpinned by common mechanisms.Genes Nutr,4,243-250.
50. Swoboda, KJ,Hyland, K(2002).Diagnosis and treatment of neurotransmitter-related disorders.Neurol Clin,20,1143-1161.
51. Wang, X,Zhang, A,Sun, H(2012).Future perspectives of Chinese medical formulae: chinmedomics as an effector.Omics,16,414-421.
52. Wattanapitayakul, SK,Chularojmontri, L,Herunsalee, A,Charuchongkolwongse, S,Chansuvanich, N(2008).Vasorelaxation and antispasmodic effects of Kaempferia parvi-flora ethanolic extract in isolated rat organ studies.Fitoterapia.,79,214-216.
53. Wattanathorn, J,Pangpookiew, P,Sripanidkulchai, K,Muchimapura, S,Sripanidkuchai, B(2007).Evaluation of the anxiolytic and antidepressant effects of alcoholic extract of Kaempferia parviflora in aged rats.Am J Agric Biol Sci.,2,94-98.
54. Wilding, C,Bell, K,Funke, S,Beck, S,Pfeiffer, N,Grus, FH(2015).GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57.J Pharmacol Sci.,127,298-304.
55. Wongsinkongman, P,Mongkolchaipak, N,Chansuvanich, N,Techadumrongsin, Y,Boonruad, T(2003).Quality evaluation of crude drugs and volatile oil of Krachai-dam rhizomes.Bull Dep Med Sci.,45,1-16.
56. Wutythamawech, W(1997).Encyclopedia of Thai Herbs.Bangkok:OS Printing.
57. Yende, SR,Harle, UN,Chaugule, BB(2014).Therapeutic potential and health benefits of Sargassumspecies.Pharmacogn Rev.,8,1.
58. Yenjai, C,Prasanphen, K,Daodee, S,Wongpanich, V,Kittakoop, P(2004).Bioactive flavonoids from Kaempferia parviflora.Fitoterapia,75,89-92.
59. Youn, K,Lee, J,Ho, C-T,Jun, M(2016).Discovery of polymethoxyflavones from black ginger (Kaempferia parviflora) as potential β-secretase (BACE1) inhibitors.J Funct Foods,20,567-574.
60. Zachariah, TJ,Leela, N,Maya, K(2011).Chemical composition of leaf oils of Myristica beddomeii (King), Myristica fragrans (Houtt.) and Myristica mala-barica (Lamk.).J Spices Aromat Crop.,17
61. Zhou, Y,Li, Z,Tang, F,Ge, R(2016).Proteomics annotate therapeutic properties of a traditonal Tibetan medicine-Tsantan Sumtang targeting and regulating multiple perturbed pathways.J Ethnopharmacol.,181,108-117.